Australian Bauxite Ltd (ASX:ABX) provides the Company's Half Yearly Report.
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to present a set of proposed resolutions and explanatory statements, which will see the merger of Medical Cannabis Limited into the Company and the acquisition of MedCan Australia, enabling the Company to have all the licences and facilities currently needed, to progress the Cannabis business and humanitarian goals of the company.
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to advise that it has entered into a Heads of Agreement with Sebastian and Samuel Edwards to acquire their Health Food Brands.
Australian Bauxite Limited (ASX:ABX) is pleased to announce that its wholly-owned subsidiary, ALCORE Limited will have global licence rights for bauxite refining using the ALCORE technology.
The Board of Queensland Bauxite (ASX:QBL) is pleased to announce a materially positive update regarding the company's research into the use of medical cannabis in autoimmune disease treatment.
Queensland Bauxite Ltd (ASX:QBL) provides the Company's Quarterly Report.
Further to the Transformation Announcement made on 20 June 2018, the Board of Queensland Bauxite Limited (ASX:QBL) has recognised that due to current market conditions, the intended capital raise at 8c is no longer an immediate practical option. As a result, the Board has decided to amend the raising price for the recompliance.
Banking & Finance
- Goldfields Money Ltd (ASX:GMY) Finsure Transaction Completion
- Goldfields Money Ltd (ASX:GMY) Shareholder Vote Approving Finsure Transaction
- Goldfields Money Ltd (ASX:GMY) Successful $20 Million Capital Raising and Finsure Transaction Update
Oil Gas & Energy
- Liquefied Natural Gas Ltd (ASX:LNG) 2018 Annual Report
- Cobalt Blue Holdings Limited (ASX:COB) Update on Progress with the Bankable Feasibility Study
- Cobalt Blue Holdings Limited (ASX:COB) CEO's Letter to Shareholders